about us
funding & grants
Every breakthrough is a collective effort.
At Exeliom Biosciences, we firmly believe that our partners
drive us closer to completing our mission.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 960623
Crohn’s & Colitis Foundation
This project has received funding from the Crohn’s & Colitis Foundation.
This project has been funded by the Plan de Relance 2030 - Innovation Biotherapies program, supported by Bpifrance.
Exeliom Biosciences would like to thank the strong and early support of the following organizations:
